Fem1b Inhibitors

Tech ID: 32345 / UC Case 2021-139-0

Patent Status

Patent Pending

Brief Description

UC Berkeley researchers have discovered novel, specific Fem1b inhibitors. Fem1b is essential in lymphoma and lung cancer cells.  Fem1b inhibition could be beneficial in cancer, metabolic disease, obesity, diabetes and other diseases. 

Suggested uses

  • therapeutics

Learn About UC TechAlerts - Save Searches and receive new technology matches


  • Rape, Michael

Other Information

Categorized As